Biosig ai sciences selected for nvidia inception partnership program to support r&d collaboration on ai medical device platform for hospitals

Westport, ct, july 20, 2023 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) (“biosig” or the “company”), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced that its subsidiary biosig ai sciences, inc. (bais) was selected to join nvidia inception , a program designed to partner with companies revolutionizing industries with advancements in artificial intelligence (ai) and data sciences.
BSGM Ratings Summary
BSGM Quant Ranking